Parallel Advisors
BRTX icon

Parallel Advisors’s BioRestorative Therapies BRTX Stock Holding History

Parallel Advisors’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2 Buy
+1
New +$5 ﹤0.01% 4027

Other funds holding BRTX

SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Rossby Financial
Rossby Financial Melbourne, Florida $673M AUM 21.47% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Parallel Advisors's BRTX Position: Q3 2026 in Review

Parallel Advisors opened a new position in BioRestorative Therapies (BRTX) in Q3 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #4027 among its holdings.

5 funds tracked by Wall St. Rank hold BRTX as of Q3 2026.

  • Parallel Advisors held 1 share of BioRestorative Therapies worth $2 as of Q3 2026.
  • BioRestorative Therapies was a new Parallel Advisors position in Q3 2026.
  • BioRestorative Therapies made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #4027 holding.
  • 5 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.